Iwamoto M, Ahnen D J, Franklin W A, Maltzman T H
Department of Medicine and Department of Pathology, University of Colorado Health Sciences Center, Denver, CO 80262, USA.
Carcinogenesis. 2000 Nov;21(11):1935-40. doi: 10.1093/carcin/21.11.1935.
Mutations of the APC gene are thought to be early events in the process of colorectal carcinogenesis. Although the complete function(s) of the APC gene product is not known, it has been shown that the APC protein interacts with beta-catenin in a multi-protein complex to regulate the level of expression of beta-catenin. Loss of normal APC protein function can lead to an accumulation of beta-catenin in the cytosol and the nucleus. Immunohistochemical methods were used to determine the relationship between APC and beta-catenin protein expression in human colonic tissues (150 normal, 9 hyperplastic, 58 adenomas and 83 carcinomas) and 12 paired samples of normal and cancer tissue in mouse colon. In all samples of normal human and mouse colonic mucosa and in human hyperplastic polyps both APC and beta-catenin immunoreactivity were present in colonocytes. APC expression was cytoplasmic, with maximal immunoreactivity in the goblet cells. beta-Catenin expression was predominantly localized to the plasma membrane, with no nuclear immunoreactivity. APC immunoreactivity was absent in all of the mouse adenocarcinomas and 83% of the human colon cancers. All of the human and mouse carcinomas had nuclear and cytoplasmic beta-catenin expression. In contrast, only 29% of the 58 colonic adenomas were completely negative for APC immunoreactivity. Regardless of the presence or absence of APC, all of the adenomas had cytoplasmic and nuclear beta-catenin immunoreactivity. Many colonic adenomas retain expression of full-length APC protein whereas it is usually lost in colorectal cancers. Regardless of the status of APC protein expression, beta-catenin protein was found in the cytoplasm and nucleus of all neoplastic colonic mucosa. The dissociation between loss of expression of APC and accumulation of beta-catenin in the nucleus suggests that inactivation of both alleles of the APC gene may not be required for beta-catenin nuclear accumulation in colonic adenomas.
APC基因的突变被认为是结直肠癌发生过程中的早期事件。尽管APC基因产物的完整功能尚不清楚,但已表明APC蛋白在多蛋白复合物中与β-连环蛋白相互作用,以调节β-连环蛋白的表达水平。正常APC蛋白功能的丧失可导致β-连环蛋白在细胞质和细胞核中积累。采用免疫组织化学方法测定人结肠组织(150例正常组织、9例增生性组织、58例腺瘤和83例癌)以及小鼠结肠12对正常组织和癌组织中APC与β-连环蛋白蛋白表达之间的关系。在所有正常人及小鼠结肠黏膜样本以及人增生性息肉中,结肠细胞均存在APC和β-连环蛋白免疫反应性。APC表达位于细胞质中,在杯状细胞中免疫反应性最强。β-连环蛋白表达主要定位于质膜,无核免疫反应性。所有小鼠腺癌和83%的人结肠癌中均无APC免疫反应性。所有人类和小鼠癌均有核及细胞质β-连环蛋白表达。相比之下,58例结肠腺瘤中只有29%的APC免疫反应性完全阴性。无论是否存在APC,所有腺瘤均有细胞质和细胞核β-连环蛋白免疫反应性。许多结肠腺瘤保留全长APC蛋白的表达,而在结直肠癌中通常会丢失。无论APC蛋白表达状态如何,在所有肿瘤性结肠黏膜的细胞质和细胞核中均发现β-连环蛋白。APC表达缺失与β-连环蛋白在细胞核中积累之间的分离表明,结肠腺瘤中β-连环蛋白核积累可能不需要APC基因的两个等位基因均失活。